The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Intravenous Immune Globulin in the Therapy of Myocarditis and Acute Cardiomyopathy
Abstract
Background Although an autoimmune pathogenesis has been postulated for dilated cardiomyopathy, immunosuppressive therapy has not been shown to be effective in clinical trials. Immune modulatory therapy with immune globulin is an effective therapy for Kawasaki disease in children, and recent data suggest that it improves ventricular function in children with new-onset dilated cardiomyopathies. The role of immune globulin therapy in adults with this disorder has not previously been evaluated. Methods and Results Ten patients were treated with high-dose intravenous immune globulin infusions (2 g/kg). All were hospitalized with NYHA class III to IV heart failure, left ventricular ejection fraction (LVEF) <0.40, and symptoms for <6 months at the time of presentation. One patient died before the completion of therapy. The remaining 9 were discharged, and LVEF was reassessed 12 months after therapy. LVEF improved from 0.24±0.02 (mean±SEM) at baseline to 0.41±0.04 at follow-up ( P =.003). All 9 patients improved functionally to NYHA class I to II, and there have been no subsequent hospitalizations for heart failure during the course of follow-up. Conclusions In this series of patients with new-onset dilated cardiomyopathy treated with high-dose immune globulin, LVEF improved 17 EF units. The effectiveness of intravenous immune globulin therapy in this disorder should be evaluated in a randomized, multicenter trial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Clinical Trial of Immunosuppressive Therapy for Myocarditis
Mason, J. W., O'Connell, J. B., Herskowitz, A., Rose, N. R., McManus, B. M., Billingham, M. E., & Moon, T. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508033330501 · Cited by 1,274
Cited by
Feldman, A. M., & McNamara, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431908 · Cited by 958
Self-citationControlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy
McNamara, D. M., Holubkov, R., Starling, R. C., Dec, G. W., Loh, E., Torre-Amione, G., Gass, A., Janosko, K., Tokarczyk, T., Kessler, P., et al. (2001) · Circulation · doi:10.1161/01.cir.103.18.2254 · Cited by 560
Self-citationAdvances in the Understanding of Myocarditis
Liu, P. P., & Mason, J. W. (2001) · Circulation · doi:10.1161/hc3401.095198 · Cited by 494
Blauwet, L. A., & Cooper, L. T. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.11.006 · Cited by 374
Immunomodulating Therapy With Intravenous Immunoglobulin in Patients With Chronic Heart Failure
Gullestad, L., Aass, H., Fjeld, J. G., Wikeby, L., Andreassen, A. K., Ihlen, H., Simonsen, S., Kjekshus, J., Nitter-Hauge, S., Ueland, T., et al. (2001) · Circulation · doi:10.1161/01.cir.103.2.220 · Cited by 349
Metadata
- Authors
- McNamara, D. M., Rosenblum, W. D., Janosko, K. M., Trost, M. K., Villaneuva, F. S., Demetris, A. J., Murali, S., & Feldman, A. M.
- Venue
- Circulation
- Published
- 1997-06-03
- Volume
- 95
- Issue
- 11
- Pages
- 2476-2478
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2020929571
- Cited by
- 239
- References
- 1
- FWCI
- 8.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intravenous Immune Globulin in the Therapy of Myocarditis and Acute Cardiomyopathy. https://app.cochat.ai/papers/10.1161/01.cir.95.11.2476
- The paper
- McNamara, D. M., Rosenblum, W. D., Janosko, K. M., Trost, M. K., Villaneuva, F. S., Demetris, A. J., Murali, S., & Feldman, A. M. (1997). Intravenous Immune Globulin in the Therapy of Myocarditis and Acute Cardiomyopathy. Circulation. https://doi.org/10.1161/01.cir.95.11.2476
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.